| Date(s) |
Auteur(s) |
Titre de l’article, lien et remarques entre crochets |
| |
|
|
| 13/09/2016 |
Stat |
Ego, ambition, and turmoil: Inside one of biotech’s most secretive startups (Moderna, mRNA, Stéphane Bancel) |
| 11/07/2016 |
Phys Life Rev. |
Mathematical models to characterize early epidemic growth: A Review, Gerardo Chowell et al. |
| 05/2016 |
J. of Virus Eradication |
SARS coronavirus has antibody-dependent enhancement (ADE) effect through the autologous antibodies against envelope spikes on Fcγ receptor expressing cells [SARS-CoV-1] |
| 30/03/2016 |
ACS Infect. Dis. |
Immunodominant SARS Coronavirus Epitopes in Humans Elicited both Enhancing and Neutralizing Effects on Infection in Non-human Primates, Qidi Wang et al. (SARS-CoV, ADE) |
| 16/03/2016 |
PNAS |
SARS-like WIV1-CoV poised for human emergence, Vineet D. Menachery, ... and Ralph S. Baric |
| 09/11/2015 |
Nature medicine |
A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence, Vineet D Menachery, ..., Zhengli-Li Shi & Ralph S Baric |
| 19/09/2014 |
Nature |
mRNA-based therapeutics — developing a new class of drugs, Ugur Sahin, Katalin Karikó & Özlem Türeci |
| 17/03/2014 |
Libération |
Comment les cigarettiers ont roulé le monde entier (Big Tobacco, Golden Holocaust, Robert N. Proctor) |
| 13/03/2014 |
Patents |
Removal of DNA fragments in mRNA production process, Stephane Bancel, Moderna, Patent US10077439B2 [activation of innate response, potential to be oncogenic] |
| 08/01/2013 |
IHU Marseille |
Cours de Didier Raoult (L3) : Les infections au XXIe siècle [Pourquoi pas de vaccin contre les trois "big three" de l'OMS : HIV, tuberculose, paludisme - SARS-CoV n°1 à 0:20:40 - Prédictions de Ferguson - Lavage des mains contre les virus respiratoires et masques - Virus d'hiver - Figatelli, hépatite E et PCR, etc.] |
| 04/12/2012 |
Nature Cell Res. |
Anti-malaria drug chloroquine is highly effective in treating avian influenza A H5N1 virus infection in an animal model, Yiwu Yan et al. |
| 26/04/2012 |
Le Figaro |
La direction d'AstraZeneca débarquée (Louis Schweitzer président) |
| 07/07/2011 |
Expert Opin Drug Metab Toxicol. |
Azithromycin plus chloroquine: combination therapy for protection against malaria and sexually transmitted infections in pregnancy |
| 01/02/2011 |
Sénat |
La gestion d'une crise sanitaire : la pandémie de grippe A (H1N1) |
| 04/11/2010 |
PLOS |
Zn(2+) inhibits coronavirus and arterivirus RNA polymerase activity in vitro and zinc ionophores block the replication of these viruses in cell culture, Aartjan Velthuis, ...Ralph S Baric et al. |
| 11/02/2010 |
Eur Respir J. |
Azithromycin induces anti-viral responses in bronchial epithelial cells, V Gielen et al. |
| 24/05/2009 |
The Times |
Billionaire club in bid to curb overpopulation (Bill Gates, David Rockefeller Jr, Warren Buffett, George Soros) |
| 03/05/2009 |
WHO/OMS |
Advice on the use of masks in the community setting in Influenza A (H1N1) outbreaks |
| 09/02/2009 |
Nature |
The spike protein of SARS-CoV — a target for vaccine and therapeutic development, Lanying Duet al. |
| 01/10/2008 |
Journal of Infectious Diseases |
Predominant Role of Bacterial Pneumonia as a Cause of Death in Pandemic Influenza: Implications for Pandemic Influenza Preparedness, Anthony Fauci |
| 10/04/2007 |
PNAS |
Extracellular RNA constitutes a natural procoagulant cofactor in blood coagulation, Christian Kannemeier et al. |
| --/--/2006 |
Ralph S. Baric |
Synthetic Viral Genomics: Risks and Benefits for Science and Society, Ralph S. Baric, University of North Carolina at Chapel Hill |
| 01/07/2006 |
Clinical Chemistry |
Preparation of a Chimeric Armored RNA as a Versatile Calibrator for Multiple Virus Assays, Qiuying Huang et al. (SARS-CoV1 and SARS-CoV2) |
| 14/09/2005 |
JORF |
Décret n° 2005-1181 du 14 septembre 2005 portant publication de l'accord relatif à la coopération entre le Gouvernement de la République française et le Gouvernement de la République populaire de Chine en matière de prévention et de lutte contre les maladies infectieuses émergentes, signé à Pékin le 9 octobre 2004 (P4 Wuhan) |
| 29/08/2005 |
US DOD |
Agreement between the Department of Defense of the USA and the Ministry of Health of Ukraine Concerning Cooperation in the Area of Prevention of Proliferation of Technology, Pathogens and Expertise that could be Used in the Development of Biological Weapons |
| 22/08/2005 |
Virology Journal |
Chloroquine is a potent inhibitor of SARS coronavirus infection and spread, Vincent et al. [SARS-CoV n°1 découvert en Chine en 2002] |
| 10/01/2005 |
Nature |
Caution raised over SARS vaccine (Jab against one strain might worsen infection with others) |
| 00/08/2004 |
The Lancet |
SARS, emerging infections, and bioterrorism preparedness, Dr Stephen G Weber et al. |
| 15/01/2004 |
Nature |
Detection of integration of plasmid DNA into host genomic DNA following intramuscular injection and electroporation, Z Wang et al. |
| 00/11/2003 |
The Lancet |
Effects of chloroquine on viral infections: an old drug against today's diseases, Savarino et al. [HIV, SARS, antiviral and immunomodulatory effects] |
| 20/10/2003 |
PNAS |
Reverse genetics with a full-length infectious cDNA of severe acute respiratory syndrome coronavirus, Boyd Yount, ... and Ralph S. Baric |
| 28/04/2003 |
US patent |
Antiviral agents for the treatment, control and prevention of infections by coronaviruses (US7151163B2, Sequoia Pharmaceuticals Inc) |
| 25/04/2003 |
US patent |
Coronavirus isolated from humans (US7220852B1, CDC) |
| 19/10/1999 |
J. Cell. Physiol. |
Gene therapy using SV40-derived vectors: What does the future hold?, David S. Strayer (simian virus-40) |
| 23/06/1989 |
Université de Nancy |
Thèse de médecine de François Braun : Les intoxications aïgues à la chloroquine (à propos de 23 observations) |
